Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide

Area of Science:

• Physiology
• Vascular Biology
• Inflammation Research

Background:

• Microvascular dysfunction, characterized by leukocyte-endothelial cell adhesion and altered nitric oxide (NO) metabolism, is central to ischemia/reperfusion (I/R) injury.
• Endothelial cell dysfunction and increased vascular permeability contribute to tissue damage following I/R events.

Purpose of the Study:

• To investigate whether NO donors can mitigate reperfusion-induced venular albumin leakage.
• To determine the role of NO in modulating leukocyte-endothelial cell interactions during I/R.

Main Methods:

• Monitoring leukocyte adherence, emigration, and albumin extravasation in rat mesenteric postcapillary venules subjected to a 20-minute ischemia and 30-minute reperfusion protocol.
• Administering NO donors (sodium nitroprusside, spermine-NO, SIN1) and assessing their impact on I/R-induced responses.
• Measuring plasma nitrate/nitrite levels and observing platelet-leukocyte aggregation and mast cell degranulation.

Main Results:

• The ischemia/reperfusion (I/R) protocol significantly increased leukocyte adherence, emigration, and albumin leakage.
• NO donors markedly reduced I/R-induced leukocyte adherence/emigration and albumin leakage.
• NO donors also attenuated platelet-leukocyte aggregation and mast cell degranulation, while plasma nitrate/nitrite levels decreased post-I/R.

Conclusions:

• Nitric oxide (NO) plays a protective role in attenuating I/R-induced microvascular dysfunction, specifically albumin leakage.
• The protective effects of NO donors are likely mediated by reducing leukocyte-endothelial cell interactions, platelet-leukocyte aggregation, and mast cell degranulation.
• These findings highlight the therapeutic potential of NO donors in managing ischemia/reperfusion injury.